(JEN) Jenoptik - Overview
Sector: TechnologyIndustry: Electronic Components | Exchange XETRA (Germany) | Currency EUR | Market Cap: 1.690m | Total Return 30.3% in 12m
Stock: Optics, Lasers, Cameras, Sensors, Software
Total Rating 56
Risk 94
Buy Signal 1.61
| Risk 5d forecast | |
|---|---|
| Volatility | 44.2% |
| Relative Tail Risk | -18.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.89 |
| Alpha | 20.11 |
| Character TTM | |
|---|---|
| Beta | 0.918 |
| Beta Downside | 0.480 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.61% |
| CAGR/Max DD | 0.02 |
EPS (Earnings per Share)
Revenue
Description: JEN Jenoptik March 04, 2026
Jenoptik AG, a German company founded in 1846, specializes in advanced photonic and smart mobility solutions.
The companys photonics offerings include imaging solutions (e.g., thermal cameras), laser technology (e.g., laser ablation systems), optics and optical systems (e.g., precision optical components), and optoelectronics (e.g., photodiodes). Photonics is a rapidly growing field with applications in diverse industries.
In smart mobility, Jenoptik provides road safety solutions such as speed enforcement and red light cameras. This sector benefits from increasing global investment in intelligent transportation systems.
Jenoptik serves a broad range of sectors, including automotive, defense, electronics, medical, industrial, and semiconductor equipment. The semiconductor equipment sector is cyclical but driven by long-term trends in digitalization.
For a deeper dive into Jenoptiks financial performance and market position, continue your research on ValueRay.
Headlines to watch out for
- Semiconductor equipment demand drives high-precision optics sales
- Automotive industry investment impacts laser and metrology orders
- Government spending on road safety solutions boosts mobility segment
- Global economic slowdown could reduce industrial technology demand
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 72.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.46 > 1.0 |
| NWC/Revenue: 18.44% < 20% (prev 29.43%; Δ -10.99% < -1%) |
| CFO/TA 0.10 > 3% & CFO 171.7m > Net Income 72.6m |
| Net Debt (368.6m) to EBITDA (198.3m): 1.86 < 3 |
| Current Ratio: 1.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (57.5m) vs 12m ago 1.43% < -2% |
| Gross Margin: 31.95% > 18% (prev 0.34%; Δ 3.16k% > 0.5%) |
| Asset Turnover: 63.08% > 50% (prev 66.18%; Δ -3.10% > 0%) |
| Interest Coverage Ratio: 4.31 > 6 (EBITDA TTM 198.3m / Interest Expense TTM 28.0m) |
Altman Z'' 3.60
| A: 0.12 (Total Current Assets 542.4m - Total Current Liabilities 348.0m) / Total Assets 1.66b |
| B: 0.35 (Retained Earnings 583.3m / Total Assets 1.66b) |
| C: 0.07 (EBIT TTM 120.5m / Avg Total Assets 1.67b) |
| D: 1.15 (Book Value of Equity 780.7m / Total Liabilities 679.4m) |
| Altman-Z'' Score: 3.60 = AA |
Beneish M -3.05
| DSRI: 1.02 (Receivables 191.3m/197.5m, Revenue 1.05b/1.11b) |
| GMI: 1.07 (GM 31.95% / 34.19%) |
| AQI: 0.99 (AQ_t 0.42 / AQ_t-1 0.42) |
| SGI: 0.95 (Revenue 1.05b / 1.11b) |
| TATA: -0.06 (NI 72.6m - CFO 171.7m) / TA 1.66b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of JEN shares?
As of March 26, 2026, the stock is trading at EUR 29.26 with a total of 555,533 shares traded.
Over the past week, the price has changed by +12.28%, over one month by +3.69%, over three months by +50.59% and over the past year by +30.29%.
Over the past week, the price has changed by +12.28%, over one month by +3.69%, over three months by +50.59% and over the past year by +30.29%.
Is JEN a buy, sell or hold?
Jenoptik has no consensus analysts rating.
What are the forecasts/targets for the JEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.5 | -2.6% |
| Analysts Target Price | - | - |
JEN Fundamental Data Overview March 26, 2026
Market Cap USD = 1.69b (1.46b EUR * 1.1562 EUR.USD)
P/E Trailing = 21.4622
P/E Forward = 16.2602
P/S = 1.3871
P/B = 1.4642
P/EG = 1.1285
Revenue TTM = 1.05b EUR
EBIT TTM = 120.5m EUR
EBITDA TTM = 198.3m EUR
Long Term Debt = 416.9m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 127.6m EUR (from shortTermDebt, last quarter)
Debt = 419.6m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 368.6m EUR (from netDebt column, last quarter)
Enterprise Value = 1.82b EUR (1.46b + Debt 419.6m - CCE 59.1m)
Interest Coverage Ratio = 4.31 (Ebit TTM 120.5m / Interest Expense TTM 28.0m)
EV/FCF = 20.57x (Enterprise Value 1.82b / FCF TTM 88.6m)
FCF Yield = 4.86% (FCF TTM 88.6m / Enterprise Value 1.82b)
FCF Margin = 8.41% (FCF TTM 88.6m / Revenue TTM 1.05b)
Net Margin = 6.89% (Net Income TTM 72.6m / Revenue TTM 1.05b)
Gross Margin = 31.95% ((Revenue TTM 1.05b - Cost of Revenue TTM 717.2m) / Revenue TTM)
Gross Margin QoQ = 33.24% (prev 31.48%)
Tobins Q-Ratio = 1.10 (Enterprise Value 1.82b / Total Assets 1.66b)
Interest Expense / Debt = 0.84% (Interest Expense 3.54m / Debt 419.6m)
Taxrate = 27.74% (8.33m / 30.0m)
NOPAT = 87.1m (EBIT 120.5m * (1 - 27.74%))
Current Ratio = 1.56 (Total Current Assets 542.4m / Total Current Liabilities 348.0m)
Debt / Equity = 0.43 (Debt 419.6m / totalStockholderEquity, last quarter 974.9m)
Debt / EBITDA = 1.86 (Net Debt 368.6m / EBITDA 198.3m)
Debt / FCF = 4.16 (Net Debt 368.6m / FCF TTM 88.6m)
Total Stockholder Equity = 964.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.35% (Net Income 72.6m / Total Assets 1.66b)
RoE = 7.53% (Net Income TTM 72.6m / Total Stockholder Equity 964.6m)
RoCE = 8.72% (EBIT 120.5m / Capital Employed (Equity 964.6m + L.T.Debt 416.9m))
RoIC = 8.14% (NOPAT 87.1m / Invested Capital 1.07b)
WACC = 7.29% (E(1.46b)/V(1.88b) * Re(9.21%) + D(419.6m)/V(1.88b) * Rd(0.84%) * (1-Tc(0.28)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.25%
[DCF] Terminal Value 83.64% ; FCFF base≈92.1m ; Y1≈110.8m ; Y5≈178.4m
[DCF] Fair Price = 56.45 (EV 3.60b - Net Debt 368.6m = Equity 3.23b / Shares 57.2m; r=7.29% [WACC]; 5y FCF grow 21.65% → 3.0% )
EPS Correlation: 18.09 | EPS CAGR: -6.18% | SUE: 0.31 | # QB: 0
Revenue Correlation: 54.78 | Revenue CAGR: 16.98% | SUE: -1.71 | # QB: 0
EPS next Year (2026-12-31): EPS=1.74 | Chg7d=+0.000 | Chg30d=+0.047 | Revisions Net=+2 | Growth EPS=+33.6% | Growth Revenue=+7.1%
P/E Trailing = 21.4622
P/E Forward = 16.2602
P/S = 1.3871
P/B = 1.4642
P/EG = 1.1285
Revenue TTM = 1.05b EUR
EBIT TTM = 120.5m EUR
EBITDA TTM = 198.3m EUR
Long Term Debt = 416.9m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 127.6m EUR (from shortTermDebt, last quarter)
Debt = 419.6m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 368.6m EUR (from netDebt column, last quarter)
Enterprise Value = 1.82b EUR (1.46b + Debt 419.6m - CCE 59.1m)
Interest Coverage Ratio = 4.31 (Ebit TTM 120.5m / Interest Expense TTM 28.0m)
EV/FCF = 20.57x (Enterprise Value 1.82b / FCF TTM 88.6m)
FCF Yield = 4.86% (FCF TTM 88.6m / Enterprise Value 1.82b)
FCF Margin = 8.41% (FCF TTM 88.6m / Revenue TTM 1.05b)
Net Margin = 6.89% (Net Income TTM 72.6m / Revenue TTM 1.05b)
Gross Margin = 31.95% ((Revenue TTM 1.05b - Cost of Revenue TTM 717.2m) / Revenue TTM)
Gross Margin QoQ = 33.24% (prev 31.48%)
Tobins Q-Ratio = 1.10 (Enterprise Value 1.82b / Total Assets 1.66b)
Interest Expense / Debt = 0.84% (Interest Expense 3.54m / Debt 419.6m)
Taxrate = 27.74% (8.33m / 30.0m)
NOPAT = 87.1m (EBIT 120.5m * (1 - 27.74%))
Current Ratio = 1.56 (Total Current Assets 542.4m / Total Current Liabilities 348.0m)
Debt / Equity = 0.43 (Debt 419.6m / totalStockholderEquity, last quarter 974.9m)
Debt / EBITDA = 1.86 (Net Debt 368.6m / EBITDA 198.3m)
Debt / FCF = 4.16 (Net Debt 368.6m / FCF TTM 88.6m)
Total Stockholder Equity = 964.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.35% (Net Income 72.6m / Total Assets 1.66b)
RoE = 7.53% (Net Income TTM 72.6m / Total Stockholder Equity 964.6m)
RoCE = 8.72% (EBIT 120.5m / Capital Employed (Equity 964.6m + L.T.Debt 416.9m))
RoIC = 8.14% (NOPAT 87.1m / Invested Capital 1.07b)
WACC = 7.29% (E(1.46b)/V(1.88b) * Re(9.21%) + D(419.6m)/V(1.88b) * Rd(0.84%) * (1-Tc(0.28)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.25%
[DCF] Terminal Value 83.64% ; FCFF base≈92.1m ; Y1≈110.8m ; Y5≈178.4m
[DCF] Fair Price = 56.45 (EV 3.60b - Net Debt 368.6m = Equity 3.23b / Shares 57.2m; r=7.29% [WACC]; 5y FCF grow 21.65% → 3.0% )
EPS Correlation: 18.09 | EPS CAGR: -6.18% | SUE: 0.31 | # QB: 0
Revenue Correlation: 54.78 | Revenue CAGR: 16.98% | SUE: -1.71 | # QB: 0
EPS next Year (2026-12-31): EPS=1.74 | Chg7d=+0.000 | Chg30d=+0.047 | Revisions Net=+2 | Growth EPS=+33.6% | Growth Revenue=+7.1%